Kedudukan dalam Saham
#33662
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
Harga Saham
$0.07591393
Disegerakkan terakhir: 2026-08-14
Perubahan (1 tahun)
-41.05%
Perdagangan TME Pharma N.V. (ALTME)
Harga ALTME dengan permodalan pasaran b
Modal pasaran bagi TME Pharma N.V.(ALTME)
Modal Pasaran: $7.15M
Sehingga August 2026, TME Pharma N.V. mempunyai modal pasaran sebanyak $7.15M. Ini menjadikan TME Pharma N.V. syarikat ke-33662nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran TME Pharma N.V. dari 2016 hingga 2026
ALTME berbanding dengan 5 teratas yang paling popular stocks
| Harga ALTME |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+76,244,200.20%
|
|
|
|
|
$4.490T
|
+62,792,774.37%
|
|
|
|
|
$4.162T
|
+58,211,108.67%
|
|
|
|
|
$3.676T
|
+51,413,501.77%
|
|
|
|
|
$2.833T
|
+39,619,964.72%
|
